Electrostatic potential and binding of drugs to the minor groove of DNA

Zimmer, 1975, Effects of the antibiotics netropsin and distamycin A on the structure and function of nucleic acids, Progress Nucleic Acid Res. and Mol. Biol., 15, 285, 10.1016/S0079-6603(08)60122-1 Braithwaite, 1980, Existence of an extended series of antitumour compounds which bind to deoxyribonucleic acid by nonintercalative means, Biochemistry, 19, 1101, 10.1021/bi00547a009 Baguely, 1982, Nonintercalative DNA-binding antitumour compounds, Molecular and Cellular Biochemistry, 43, 167 Pullman, 1981, Structural factors involved in the binding of netropsin and distamycin A to nucleicacids, Studio Biophys., 86, 95 Lavery, 1986, Binding of non-intercalating antibiotics to B-DNA: a theoretical study taking into account nucleic acid flexibility, J. Biomol. Struct, and Dynam., 3, 1155, 10.1080/07391102.1986.10508492 Arnott, 1977, Secondary structures of polynucleotides, 87 Singh, 1984, An approach to computing electrostatic charges for molecules, J. Comput. Chem., 5, 129, 10.1002/jcc.540050204 Weiner, 1986, An all atom force field for simulations of proteins and nucleic acids, J. Comput. Chem., 7, 230, 10.1002/jcc.540070216 Quarendon, 1984, Display of quantum mechanical properties on van der Waals surfaces, J. Mol. Graph., 2, 4, 10.1016/0263-7855(84)80021-1 Quarendon, 1986, CESTA Second Image Symposium, Nice,, 2, 615 Reynolds, 1986, Ab initio calculations relevant to the mechanism of chemical carcinogenesis by nitrosamines, Part 5: The role of diazomethane, J. Chem. Soc. Perkin II, 1927, 10.1039/p29860001927 Singer, 1979, N-nitroso alkylating agents: formation and persistence of alkyl derivatives in mammalian nucleic acids as contributing factors in carcinogenesis, J. Natl. Cancer Inst., 62, 1329 Goodford, 1985, A computational procedure for determining energetically favourable sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021/jm00145a002 Kennedy, 1980, The hypoxic tumor cell: a target for selective cancer chemotherapy, Biochem. Pharmacol., 29, 1, 10.1016/0006-2952(80)90235-X Reynolds, 1987, ntroducing selectivity into dihydrofolate reductase inhibitors, Anti-Cancer Drug Design, 1, 291